Agilent Welcomes Eric Gerber
Agilent Technologies has announced the appointment of Eric Gerber as the company’s new Senior Vice President of strategy and corporate development.
Agilent Technologies (Santa Clara, California, USA) has announced the appointment of Eric Gerber as the company’s new Senior Vice President of strategy and corporate development.
Gerber will lead the corporate development team in identifying, developing, and evaluating mergers and acquisitions (M&A) plans globally while collaborating with the businesses groups to help drive critical growth initiatives across the company.
“Eric is an accomplished leader with a proven track record of developing and executing M&A and innovation-led growth strategies,” said Mike McMullen, Agilent President and CEO. “His broad experience across the field of scientific instrumentation, consumables, and services and his deep technical expertise will serve Agilent well as we look to expand our portfolio and global footprint in the next phase of the company’s growth journey.”
Gerber joins Agilent from Danaher where he served as vice president of business development for seven years at Sciex, an operating company of Danaher. His experience includes M&A, strategic planning, marketing, and disruptive innovation. For more information, please visit: www.agilent.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
